Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05486637 · ClinicalTrials.gov registry record · Early Phase 1
Vocal Emotion Communication With Cochlear Implants
A Early Phase 1 study of Cochlear Hearing Loss, sponsored by Father Flanagan's Boys' Home.
- Recruiting
- Registry status
- Early Phase 1
- Development phase
- 255
- Enrollment target
- 4
- Study locations
NCT05486637: Recruiting Early Phase 1 study of Cochlear Hearing Loss, sponsored by Father Flanagan's Boys' Home.
NCT05486637 is a Early Phase 1 study of Cochlear Hearing Loss that is actively recruiting participants, run by Father Flanagan's Boys' Home. The registered enrollment target is 255 participants, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (381% higher). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05486637, a Early Phase 1 study of Cochlear Hearing Loss, is actively recruiting participants, sponsored by Father Flanagan's Boys' Home.
- RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 255 participants
- Enrollment target
- 4
- Study locations
Study Summary
Patients with hearing loss who use cochlear implants (CIs) show significant deficits and strong unexplained intersubject variability in their perception and production of spoken emotions in speech. This project will investigate the hypothesis that "cue-weighting", or how patients utilize the different acoustic cues to emotion, accounts for significant variance in emotional communication with CIs. The results will focus on children with CIs, but parallel measures in postlingually deaf adults with CIs will be made, ensuring that results of these studies benefit social communication by CI patients across the lifespan by informing the development of technological innovations and improved clinical protocols.
Primary Outcome
Percent correct scores in vocal emotion recognition
Conditions Studied
Interventions
- BEHAVIORAL Perception of acoustic cues to emotion
- BEHAVIORAL Production of acoustic cues to emotion
Study Locations (4)
Arizona
- Arizona State University - Tempe
California
- House Institute Foundation - Los Angeles
Illinois
- Northwestern University - Evanston
Nebraska
- Boys Town National Research Hospital - Omaha
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 255 participants |
| Start Date | 2022-07-01 |
| Est. Completion | 2027-06-30 |
| Phase | Early Phase 1 |
What NCT05486637 shows while recruiting
NCT05486637 is an interventional study that assigns participants to a tested intervention. The registered 255 participants enrollment target is mid-sized for trials with a published cap, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (381% higher).
The record links to 1 condition, with Cochlear Hearing Loss appearing as the primary indexed condition, and to 2 interventions - of which Perception of acoustic cues to emotion is the first listed.
NCT05486637 reports a single indexed study location in Arizona, California, Illinois.
Frequently Asked Questions
What is clinical trial NCT05486637 about?
NCT05486637 is a clinical study titled "Vocal Emotion Communication With Cochlear Implants". Patients with hearing loss who use cochlear implants (CIs) show significant deficits and strong unexplained intersubject variability in their perception and production of spoken emotions in speech. This project will investigate the hypothesis that "cue-weighting", or how patients utilize the differe...
What is the current status of trial NCT05486637?
This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 255 participants. The study started on 2022-07-01. Estimated completion is 2027-06-30.
What conditions does trial NCT05486637 study?
This clinical trial studies the following conditions: Cochlear Hearing Loss.
What interventions are being tested in trial NCT05486637?
The interventions under investigation include: Perception of acoustic cues to emotion (BEHAVIORAL), Production of acoustic cues to emotion (BEHAVIORAL).
Who is sponsoring clinical trial NCT05486637?
This trial is sponsored by Father Flanagan's Boys' Home, which has 16 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05486637 being conducted?
This trial has 4 study locations across Arizona, California, Illinois, Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cochlear Hearing Loss
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05486637's enrollment target sits among peer trials
255 43rd of 2000 higher than 1,958 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04623424 · 255 participants
Intestinal Microbiota in Stem Cell Transplant Transplant Admission
- NCT05114798 · 255 participants · NA
Time-restricted Eating Versus Daily Continuous Calorie Restriction on Body Weight and Colorectal Cancer Risk Markers
- NCT05336188 · 255 participants · Phase 2
Neurocognitive Mechanisms Underlying Smartphone-Assisted Prevention of Relapse in Opioid Use Disorder
- NCT05616130 · 255 participants
Pathological Myeloid Activation After Sepsis and Trauma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI